SEC Filings for OncoCyte Corporation (OCX)

$ 2.85 0.00 (0.00%) Volume: 383.69k 8:00 PM EST Feb 21, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals1202/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)302/14/2020
4Statement of changes in beneficial ownership of securities102/12/2020
4Statement of changes in beneficial ownership of securities102/12/2020
4Statement of changes in beneficial ownership of securities102/12/2020
4Statement of changes in beneficial ownership of securities102/12/2020
DNotice of Exempt Offering of Securities102/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)10702/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)2601/10/2020
4Statement of changes in beneficial ownership of securities101/06/2020
4Statement of changes in beneficial ownership of securities101/06/2020
SC 13D/A[Amend] General statement of acquisition of beneficial ownership701/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)4601/06/2020
424B5Prospectus [Rule 424(b)(5)]3301/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)5012/27/2019
<<
First
<
Prev
123456789101112131415